Philip Tsai insider trades
Open-market stock purchases and sales by Philip Tsai, Chief Technical Officer at Immunome Inc, from SEC Form 4 filings since Jun 17, 2024.
Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +67%.
Companies traded
- IMNM Immunome Inc: 3 buys, last Jul 23, 2026